Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Indications”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Large-scale testing (Phase 3)UnknownNCT00295802
What this trial is testing

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP TMS S.A. 141
Early research (Phase 1)Study completedNCT01219790
What this trial is testing

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
Institut Cancerologie de l'Ouest 30
Large-scale testing (Phase 3)WithdrawnNCT00728533
What this trial is testing

Open-Label, Randomised Parallel-Group Study

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Not applicableStudy completedNCT03565289
What this trial is testing

PRospective Prostate biOmarker Study

Who this might be right for
Indication for Prostate Biopsy Due to Suspected Prostate Cancer
ProteoMediX AG 455
Testing effectiveness (Phase 2)Ended earlyNCT07068555
What this trial is testing

Prostate Cancer Vaccines

Who this might be right for
Prostate Cancer Indications
Shenzhen Geno-Immune Medical Institute 30
Not applicableUnknownNCT02577627
What this trial is testing

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerProstate Cancer+2 more
Optimata Ltd. 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Large-scale testing (Phase 3)Study completedNCT00436839
What this trial is testing

Taxotere Prostate Cancer New Indication Registration Trial in China

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Not applicableStudy completedNCT03783741
What this trial is testing

The Biopsychosocial Burden of Prostate Biopsy

Who this might be right for
Prostate Cancer
University of Campinas, Brazil 47
Testing effectiveness (Phase 2)Study completedNCT00751205
What this trial is testing

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Who this might be right for
Prostate CancerOvarian Cancer
Bayer 150
Early research (Phase 1)Study completedNCT04712396
What this trial is testing

Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Who this might be right for
Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
AstraZeneca 11
Testing effectiveness (Phase 2)Study completedNCT02649790
What this trial is testing

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Karyopharm Therapeutics Inc 277